• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.78% Nasdaq Down 1.14%

    CytRx Corporation (CYTR)

    -NasdaqCM
    3.21 Down 0.14(4.33%) 2:43PM EDT - Nasdaq Real Time Price
    Prev Close:3.35
    Open:3.25
    Bid:3.22 x 400
    Ask:3.23 x 1000
    1y Target Est:6.17
    Beta:2.3856
    Earnings Date:Apr 29 - May 3 (Est.)
    Day's Range:3.10 - 3.41
    52wk Range:1.55 - 5.00
    Volume:739,139
    Avg Vol (3m):760,225
    Market Cap:213.07M
    P/E (ttm):N/A
    EPS (ttm):-0.86
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CYTR

    Comparison

    Symbol% ChgMkt Cap
    CYTRDown 4.33%213.07M
    LLYDown 1.63%79.37B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):2,227.08
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-0.97
    Quarterly EPS Est (Mar-16) :-0.26
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    CytRx Corporation operates as a biopharmaceutical research and development company specializing in oncology. The company’s product candidate is aldoxorubicin, which is in Phase III clinical trial as a therapy for patients with soft tissue sar... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback